Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
702
+58
+9% +$19.9K 0.04% 153
2026
Q1
$227K Hold
644
– – 0.07% 106
2025
Q4
$211K Buy
+644
New +$204K 0.06% 106
2025
Q2
– Sell
-644
Closed -$201K – 109
2025
Q1
$201K Buy
+644
New +$190K 0.08% 92
2024
Q4
– Sell
-644
Closed -$208K – 97
2024
Q3
$208K Buy
+644
New +$211K 0.09% 76

Other funds holding AMGN

Atlas Wealth's AMGN Position: Q2 2026 in Review

Atlas Wealth increased its Amgen (AMGN) stake by 9% in Q2 2026, buying an estimated $19.9K and bringing the position to 702 shares worth $254K. The position accounts for 0.04% of the portfolio, ranked #153.

Atlas Wealth first reported a position in AMGN in Q3 2024 and has held it in 5 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Atlas Wealth held 702 shares of Amgen worth $254K as of Q2 2026.
  • Atlas Wealth bought 58 Amgen shares in Q2 2026, an estimated $19.9K.
  • Amgen made up 0.04% of Atlas Wealth's portfolio in Q2 2026, its #153 holding.
  • Atlas Wealth first reported a position in Amgen in Q3 2024 and has held it in 5 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Atlas Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.